Rein Therapeutics Presents Posters at ATS 2025 Conference
19 May 2025 //
PR NEWSWIRE
Rein Therapeutics Reports Q1 2025 Results and Business Update
15 May 2025 //
PR NEWSWIRE
Rein Therapeutics Start Renew Ph 2 Trial of LTI-03 in IPF Patients
12 May 2025 //
PR NEWSWIRE
Rein Therapeutics to Present at Citizens Life Sciences Conf. 2025
30 Apr 2025 //
PR NEWSWIRE
Rein Therapeutics` Abstract Accepted for ATS 2025 Conference
28 Apr 2025 //
PR NEWSWIRE
Rein Announces Publication on Caveolin-1 Peptide in IPF and PASC-F
15 Apr 2025 //
PR NEWSWIRE
Aileron Therapeutics Announces Rebranding to Rein Therapeutics
10 Jan 2025 //
PR NEWSWIRE